Patients with suspected new bladder cancer were randomly assigned 1:1 to transurethral resection of bladder tumor or ...
Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name ...
The Independent on MSN5d
‘Game changer’ immunotherapy drug could lead to increased survival rates for bladder cancer patientsThe study found that patients with muscle-invasive bladder cancer had significantly less risk of cancer progressing or ...
Medical experts in Sheffield have hailed as a "game changer" trials of a drug that could reduce the recurrence of bladder ...
StarsInsider on MSN4d
Bladder cancer: the signs, symptoms, and treatmentsBladder cancer is among the top 10 most common cancer types in the world, with approximately 573,000 new cases annually. Men ...
Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research ...
Bladder cancer presents through various symptoms, ranging from subtle changes to more noticeable signs. While some symptoms ...
Researchers discover novel targets for bladder cancer therapeutics and demonstrate that a new combination of existing drugs, including statins, blocks tumor growth in mice.
Pfizer's experimental treatment for a type of bladder cancer significantly improved the time that patients remained free of ...
The investigational anti-PD-1 monoclonal antibody is showing positive topline results from the phase 3 CREST trial.
BladderPath trial found that patients with suspected invasive bladder cancer undergoing initial mpMRI were treated faster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback